Exelixis EXEL
NASDAQ EXEL
$64.53 -0.78 (-1.19%)
At close: Oct 23, 2026 · 4:00 PM EDT

Exelixis (EXEL) Sale and Maturity of Investments (2010 - 2026)

Updated

Analysis

Exelixis (EXEL) Sale and Maturity of Investments (2010 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Investments Sold (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn -
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 308.00 Mn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn -
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 1.30 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 136.00 Mn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn -
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn -
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 1.03 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 2.12 Bn
10 Exelixis 16.06 Bn 12.40 Bn 608.03 Mn 169.27 Mn
Historic Data

Historic Data

Download Data
DateValue
Jul 3, 2026 169.27 Mn
Apr 3, 2026 225.13 Mn
Jan 2, 2026 189.34 Mn
Oct 3, 2025 221.51 Mn
Jul 4, 2025 353.10 Mn
Apr 4, 2025 258.92 Mn
Jan 3, 2025 226.16 Mn
Sep 27, 2024 167.42 Mn
Jun 28, 2024 215.28 Mn
Mar 29, 2024 268.45 Mn
Dec 29, 2023 153.49 Mn
Sep 29, 2023 311.08 Mn
Jun 30, 2023 263.14 Mn
Mar 31, 2023 310.77 Mn
Dec 30, 2022 237.99 Mn
Sep 30, 2022 326.41 Mn
Jul 1, 2022 232.74 Mn
Apr 1, 2022 267.62 Mn
Dec 31, 2021 282.70 Mn
Oct 1, 2021 381.73 Mn
API Access

Exelixis Sale and Maturity of Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=EXEL&period=max&api_key=YOUR_API_KEY